Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
21/05/2026 06:34
May 21 (Reuters) - Stayble Therapeutics AB STABL.ST: Q1 EBIT LOSS SEK 6.9 MILLION Source text: ID:nWkrbsn9KH Further company coverage: STABL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln